Annual Drug Patent Expirations for BELRAPZO
Belrapzo is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
This drug has forty-nine patent family members in thirty-one countries.
The generic ingredient in BELRAPZO is bendamustine hydrochloride. One supplier is listed for this compound. Additional details are available on the bendamustine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com